
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI
[ Tue, Mar 30th 2021 ]: WOPRAI

[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI
[ Mon, Mar 29th 2021 ]: WOPRAI

[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
[ Fri, Mar 26th 2021 ]: WOPRAI
Dan Brennan Maintained (TMO) at Strong Buy with Decreased Target to $560 on, Mar 29th, 2021


🞛 This publication is a summary or evaluation of another publication
Dan Brennan of UBS, Maintained "Thermo Fisher Scientific Inc." (TMO) at Strong Buy with Decreased Target from $588 to $560 on, Mar 29th, 2021.
Dan has made no other calls on TMO in the last 4 months.
There are 13 other peers that have a rating on TMO. Out of the 13 peers that are also analyzing TMO, 1 agrees with Dan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Katie Tryhane of "Credit Suisse" Maintained at Hold with Increased Target to $490 on, Wednesday, December 2nd, 2020
These are the ratings of the 12 analyists that currently disagree with Dan
- Paul Knight of "Keybanc" Upgraded from Hold to Buy and Held Target at $520 on, Thursday, March 18th, 2021
- Luke Sergott of "Barclays" Initiated at Buy and Held Target at $525 on, Wednesday, March 3rd, 2021
- Sung Ji Nam of "BTIG" Maintained at Strong Buy with Increased Target to $590 on, Wednesday, February 3rd, 2021
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $575 on, Tuesday, February 2nd, 2021
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $530 on, Tuesday, February 2nd, 2021
- Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $560 on, Tuesday, February 2nd, 2021
- Daniel Arias of "Stifel" Maintained at Strong Buy with Increased Target to $600 on, Tuesday, February 2nd, 2021
- Doug Schenkel of "Cowen & Co." Maintained at Buy with Increased Target to $585 on, Tuesday, February 2nd, 2021
- Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $560 on, Monday, February 1st, 2021
- Erin Wright of "Credit Suisse" Maintained at Buy with Increased Target to $580 on, Tuesday, January 12th, 2021
- Catherine Schulte of "Baird" Maintained at Buy with Increased Target to $523 on, Wednesday, December 2nd, 2020
- Stephen Unger of "Needham" Maintained at Strong Buy and Held Target at $539 on, Tuesday, December 1st, 2020